X0306 4 2019-05-06 false 0001271214 Intersect ENT, Inc. XENT 0001354228 Lehman David Aaron C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false General Counsel Common Stock 2019-05-06 4 M false 9000.00 18.00 A 30795.00 D Common Stock 2019-05-06 4 S false 9000.00 33.0224 D 21795.00 D Common Stock 2019-05-07 4 A false 11952.00 0.00 A 33747.00 D Stock Option (right to buy) 18.00 2019-05-06 4 M false 9000.00 0.00 D 2026-02-21 Common Stock 9000.00 76000.00 D Includes 17,000 Restricted Stock Units. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.15, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest on December 31, 2019. Includes 28,952 Restricted Stock Units. The vesting commencement date of the option was February 22, 2016. 25% of the shares subject to the option vested on February 22, 2017 and 1/48th of the remaining shares subject to the option will vest monthly thereafter over three (3) years. /s/ David A. Lehman 2019-05-08